These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases]. Jandus P, Harr T, Soyka MB, Landis BN. Rev Med Suisse; 2019 Oct 02; 15(665):1748-1751. PubMed ID: 31580018 [Abstract] [Full Text] [Related]
8. Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis. Stevens W, Buchheit K, Cahill KN. Curr Allergy Asthma Rep; 2015 Dec 02; 15(12):69. PubMed ID: 26475526 [Abstract] [Full Text] [Related]
9. Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease. Guillén D, Bobolea I, Calderon O, Fiandor A, Cabañas R, Heredia R, Quirce S. J Investig Allergol Clin Immunol; 2015 Dec 02; 25(2):133-5. PubMed ID: 25997307 [No Abstract] [Full Text] [Related]
11. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial. Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Kamide Y, Nakamura Y, Hamada Y, Tomita Y, Sekiya K, Tsuburai T, Izuhara K, Wakahara K, Hashimoto N, Hasegawa Y, Taniguchi M. Am J Respir Crit Care Med; 2020 Jun 15; 201(12):1488-1498. PubMed ID: 32142372 [Abstract] [Full Text] [Related]